ID   AGAP2_RAT               Reviewed;        1186 AA.
AC   Q8CGU4; Q9JHW8;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   24-JUL-2024, entry version 170.
DE   RecName: Full=Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2;
DE            Short=AGAP-2;
DE   AltName: Full=Centaurin-gamma-1;
DE            Short=Cnt-g1;
DE   AltName: Full=Phosphatidylinositol 3-kinase enhancer;
DE            Short=PIKE;
GN   Name=Agap2; Synonyms=Centg1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   INTERACTION WITH HOMER1 AND HOMER2, AND MUTAGENESIS OF PRO-187.
RC   STRAIN=Brown Norway; TISSUE=Brain;
RX   PubMed=14528310; DOI=10.1038/nn1134;
RA   Rong R., Ahn J.-Y., Huang H., Nagata E., Kalman D., Kapp J.A., Tu J.,
RA   Worley P.F., Snyder S.H., Ye K.;
RT   "PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing
RT   neuronal apoptosis.";
RL   Nat. Neurosci. 6:1153-1161(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-754, GTP-BINDING, TISSUE SPECIFICITY,
RP   INTERACTION WITH EPB41L1, SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS
RP   OF SER-414.
RX   PubMed=11136977; DOI=10.1016/s0092-8674(00)00195-1;
RA   Ye K., Hurt K.J., Wu F.Y., Fang M., Luo H.R., Hong J.J., Blackshaw S.,
RA   Ferris C.D., Snyder S.H.;
RT   "PIKE: a nuclear GTPase that enhances PI3kinase activity and is regulated
RT   by protein 4.1N.";
RL   Cell 103:919-930(2000).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH PLCG1.
RX   PubMed=11823862; DOI=10.1038/415541a;
RA   Ye K., Aghdasi B., Luo H.R., Moriarity J.L., Wu F.Y., Hong J.J., Hurt K.J.,
RA   Bae S.S., Suh P.-G., Snyder S.H.;
RT   "Phospholipase C gamma 1 is a physiological guanine nucleotide exchange
RT   factor for the nuclear GTPase PIKE.";
RL   Nature 415:541-544(2002).
RN   [4]
RP   FUNCTION.
RX   PubMed=15385964; DOI=10.1038/sj.emboj.7600392;
RA   Ahn J.-Y., Rong R., Liu X., Ye K.;
RT   "PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of
RT   NGF in the nucleus.";
RL   EMBO J. 23:3995-4006(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, INTERACTION WITH NF2, AND MUTAGENESIS OF PRO-187.
RX   PubMed=15598747; DOI=10.1073/pnas.0405971102;
RA   Rong R., Tang X., Gutmann D.H., Ye K.;
RT   "Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits
RT   phosphatidylinositol 3-kinase through binding to PIKE-L.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:18200-18205(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-679 AND LYS-687.
RX   PubMed=16263930; DOI=10.1073/pnas.0507365102;
RA   Hu Y., Liu Z., Ye K.;
RT   "Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase
RT   enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt
RT   signalings.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16853-16858(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1172, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: GTPase-activating protein (GAP) for ARF1 and ARF5, which also
CC       shows strong GTPase activity. Participates in the prevention of
CC       neuronal apoptosis by enhancing PI3 kinase activity. Aids the coupling
CC       of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase
CC       by interacting with Homer scaffolding proteins, and also seems to
CC       mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase.
CC       {ECO:0000269|PubMed:11136977, ECO:0000269|PubMed:11823862,
CC       ECO:0000269|PubMed:15385964, ECO:0000269|PubMed:16263930}.
CC   -!- ACTIVITY REGULATION: GAP activity is stimulated by phosphatidylinositol
CC       4,5-bisphosphate (PIP2) and, to a lesser extent, by
CC       phosphatidylinositol 3,4,5-trisphosphate (PIP3). Phosphatidic acid
CC       potentiates PIP2 stimulation (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with EPB41L1, PLCG1, NF2, HOMER1 and HOMER2.
CC       {ECO:0000269|PubMed:11136977, ECO:0000269|PubMed:11823862,
CC       ECO:0000269|PubMed:14528310, ECO:0000269|PubMed:15598747}.
CC   -!- INTERACTION:
CC       Q8CGU4; Q63155: Dcc; NbExp=2; IntAct=EBI-4409108, EBI-1798965;
CC       Q8CGU4; P19491: Gria2; NbExp=4; IntAct=EBI-4409108, EBI-77718;
CC       Q8CGU4; P97879: Grip1; NbExp=4; IntAct=EBI-4409108, EBI-936113;
CC       Q8CGU4; Q9Z214-1: Homer1; NbExp=4; IntAct=EBI-4409108, EBI-4410552;
CC       Q8CGU4; O08722: Unc5b; NbExp=6; IntAct=EBI-4409108, EBI-4404185;
CC       Q8CGU4; Q8IZJ1: UNC5B; Xeno; NbExp=9; IntAct=EBI-4409108, EBI-4409075;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- TISSUE SPECIFICITY: Present in cortex, hippocampus and olfactory bulb
CC       but absent in cerebellum (at protein level).
CC       {ECO:0000269|PubMed:11136977, ECO:0000269|PubMed:14528310}.
CC   -!- DOMAIN: G domain binds GTP and has GTPase activity. {ECO:0000250}.
CC   -!- DOMAIN: Arf-GAP domain interacts with G domain and may regulate its
CC       GTPase activity. {ECO:0000250}.
CC   -!- DOMAIN: PH domain binds phospholipids and is required for nuclear
CC       targeting. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the centaurin gamma-like family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF97595.1; Type=Frameshift; Note=This sequence would represent a shorter strictly nuclear isoform named PIKE-S. It may be an artifactual frameshifted form whose existence in vivo is dubious.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY128688; AAM97539.1; -; mRNA.
DR   EMBL; AF280816; AAF97595.1; ALT_FRAME; mRNA.
DR   RefSeq; NP_075415.2; NM_023026.2.
DR   AlphaFoldDB; Q8CGU4; -.
DR   SMR; Q8CGU4; -.
DR   BioGRID; 249323; 5.
DR   IntAct; Q8CGU4; 10.
DR   MINT; Q8CGU4; -.
DR   STRING; 10116.ENSRNOP00000029533; -.
DR   iPTMnet; Q8CGU4; -.
DR   PhosphoSitePlus; Q8CGU4; -.
DR   PaxDb; 10116-ENSRNOP00000029533; -.
DR   Ensembl; ENSRNOT00000031230.7; ENSRNOP00000029533.4; ENSRNOG00000025584.7.
DR   Ensembl; ENSRNOT00055045958; ENSRNOP00055037688; ENSRNOG00055026616.
DR   Ensembl; ENSRNOT00060013414; ENSRNOP00060010207; ENSRNOG00060008102.
DR   Ensembl; ENSRNOT00065026895; ENSRNOP00065021138; ENSRNOG00065016155.
DR   GeneID; 65218; -.
DR   KEGG; rno:65218; -.
DR   AGR; RGD:628844; -.
DR   CTD; 116986; -.
DR   RGD; 628844; Agap2.
DR   eggNOG; KOG0705; Eukaryota.
DR   GeneTree; ENSGT00940000158956; -.
DR   HOGENOM; CLU_007326_3_0_1; -.
DR   InParanoid; Q8CGU4; -.
DR   OMA; CPNEPTP; -.
DR   OrthoDB; 1449795at2759; -.
DR   PhylomeDB; Q8CGU4; -.
DR   TreeFam; TF317762; -.
DR   PRO; PR:Q8CGU4; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000025584; Expressed in frontal cortex and 18 other cell types or tissues.
DR   ExpressionAtlas; Q8CGU4; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0090543; C:Flemming body; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0005525; F:GTP binding; ISO:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:RGD.
DR   GO; GO:0003924; F:GTPase activity; ISO:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035014; F:phosphatidylinositol 3-kinase regulator activity; ISO:RGD.
DR   GO; GO:0030295; F:protein kinase activator activity; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:1905430; P:cellular response to glycine; IDA:RGD.
DR   GO; GO:0016197; P:endosomal transport; ISO:RGD.
DR   GO; GO:1904019; P:epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0060749; P:mammary gland alveolus development; ISO:RGD.
DR   GO; GO:0033598; P:mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; IMP:RGD.
DR   GO; GO:0033601; P:positive regulation of mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IMP:RGD.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd08836; ArfGap_AGAP; 1.
DR   CDD; cd04103; Centaurin_gamma; 1.
DR   CDD; cd01250; PH_AGAP; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   Gene3D; 1.10.220.150; Arf GTPase activating protein; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR051282; Arf-GAP_GTPase_ANK_PH.
DR   InterPro; IPR037278; ARFGAP/RecO.
DR   InterPro; IPR001164; ArfGAP_dom.
DR   InterPro; IPR038508; ArfGAP_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001806; Small_GTPase.
DR   PANTHER; PTHR45819:SF3; ARF-GAP WITH GTPASE, ANK REPEAT AND PH DOMAIN-CONTAINING PROTEIN 2; 1.
DR   PANTHER; PTHR45819; CENTAURIN-GAMMA-1A; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF01412; ArfGap; 1.
DR   Pfam; PF00071; Ras; 1.
DR   PRINTS; PR00405; REVINTRACTNG.
DR   SMART; SM00105; ArfGap; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00175; RAB; 1.
DR   SMART; SM00173; RAS; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF57863; ArfGap/RecO-like zinc finger; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS50115; ARFGAP; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS51419; RAB; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Cytoplasm; GTP-binding; GTPase activation; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..1186
FT                   /note="Arf-GAP with GTPase, ANK repeat and PH domain-
FT                   containing protein 2"
FT                   /id="PRO_0000235914"
FT   DOMAIN          670..904
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          925..1045
FT                   /note="Arf-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00288"
FT   REPEAT          1084..1113
FT                   /note="ANK 1"
FT   REPEAT          1117..1146
FT                   /note="ANK 2"
FT   ZN_FING         940..963
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00288"
FT   REGION          1..23
FT                   /note="Interaction with EPB41L1"
FT                   /evidence="ECO:0000269|PubMed:11136977"
FT   REGION          24..371
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          180..225
FT                   /note="Interactions with HOMER1 and NF2"
FT   REGION          262..384
FT                   /note="Interaction with PLCG1"
FT                   /evidence="ECO:0000269|PubMed:11823862"
FT   REGION          399..566
FT                   /note="G domain"
FT                   /evidence="ECO:0000250"
FT   REGION          576..613
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          628..666
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          759..784
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          800..844
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1145..1174
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        52..73
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        576..611
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        644..661
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         407..414
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         451..455
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         509..512
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         128
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         632
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99490"
FT   MOD_RES         744
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         746
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         802
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         921
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         979
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD9"
FT   MOD_RES         1172
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         187
FT                   /note="P->L: Abolishes interactions with HOMER1C and NF2."
FT                   /evidence="ECO:0000269|PubMed:14528310,
FT                   ECO:0000269|PubMed:15598747"
FT   MUTAGEN         414
FT                   /note="S->N: Fails to activate PI3 kinase."
FT                   /evidence="ECO:0000269|PubMed:11136977"
FT   MUTAGEN         679
FT                   /note="K->N: Abolishes phospholipid binding and nuclear
FT                   localization; when associated with N-687."
FT                   /evidence="ECO:0000269|PubMed:16263930"
FT   MUTAGEN         687
FT                   /note="K->N: Abolishes phospholipid binding and nuclear
FT                   localization; when associated with N-679."
FT                   /evidence="ECO:0000269|PubMed:16263930"
SQ   SEQUENCE   1186 AA;  124438 MW;  B9C8E987D2989378 CRC64;
     MSRGAGALQR RTTTYLISLT LVKLESVPPP PPSPSAAAVG APGARGSEPR DPGSPRGAEE
     PGKKRHERLF HRQDALWIST SSAGAGGAEP PALSPAPASP ARPVSPAPGR RLSLWAAPPG
     PPLSGGLSPD SKPGGAPSSS RRPLLSSPSW GGPEPEGRTG GGVPGSSSPH PGTGSRRLKV
     APPPPAPKPF KTVTTSGAKA GGGKGAGSRL SWPESEGKPR VKGSKSTAGT GASAVAAGGG
     GSAAVTTSGG VGAGAGARGK LSPRKGKSKT LDNSDLHPGP SAGSPPLTVP AIPVPATSVT
     AASTQPLGPA PPITLEPPAP GLKRGREGGR ASTRDRKMLK FISGIFTKST GGPPGPGPLP
     GPQGLSSSSG SRELLGAELR ASPKAVVNSQ EWTLSRSIPE LRLGVLGDVR SGKSSLIHRF
     LTGSYQVLEK PESEQYKKEM LVDGQTHLVL IREEAGAPDA KFSGWADAVI FVFSLEDESS
     FQAVSHLHGQ LISLRGEGRG GLALALVGTQ DRISASSPRV VGDARARALC TDMKRCSYYE
     TCATYGLNVD RVFQEVAQKV VTLRKQQQLL AACKSLPSSP SHSAASTPVA GQASNGGHTS
     DYSSSLPSSP NVGHRELRAE AAAVAGLSTP GSLHRAAKRR TSLFANRRGS DSEKRSLDSR
     GETTGSGRAI PIKQSFLLKR SGNSLNKEWK KKYVTLSSNG FLLYHPSIND YIHSTHGKEM
     DLLRTTVKVP GKRPPRAISA FGPSASINGL VKDMSTVQMG EGPEASTPMP SPSPSPSSLQ
     LPTDQTSKHL LKPDRNLARA LSTDCTPSGD LSPLSREPPP SPMVKKQRRK KLSTPSKTEG
     SAVQAEAKRK MWKLKSFGSL RNIYKAEENF EFLIVSSTGQ TWHFEAASFE ERDAWVQAIE
     SQILASLQCC ESSKVKLRTD SQSEAVAIQA IRNAKGNSTC VDCGAPNPTW ASLNLGALIC
     IECSGIHRNL GTHLSRVRSL DLDDWPRELT LVLTAIGNDT ANRVWESDTR GRAKPTRDSS
     REERESWIRA KYEQLLFLAP LGTTEEPLGR QLWAAVEAQD VAAVLLLLAH ARHGPLDTSV
     EDPQLRSPLH LAAELAHVVI TQLLLWYGAD VAARDAQGRT ALFYARQAGS QLCADILLQH
     GCPGEGGSTA TTPSAATTPS ITATPSPRRR SSAASLGRVD TTIALV
//
